Published 11 December 2008, doi:10.1136/bmj.a2654
Cite this as: BMJ 2008;337:a2654

Research

Christmas 2008: Sport

Mortality on Mount Everest, 1921-2006: descriptive study

Paul G Firth, anaesthetist1, Hui Zheng, statistician2, Jeremy S Windsor, specialist registrar in anaesthetics and intensive care3, Andrew I Sutherland, Wellcome research training fellow4, Christopher H Imray, vascular surgeon5, G W K Moore, professor6, John L Semple, professor7, Robert C Roach, associate professor8, Richard A Salisbury, computer analyst9

1 Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, MA 02114, USA, 2 Biostatistics Center, Massachusetts General Hospital, Boston, 3 Heart Hospital, London, 4 Nuffield Department of Surgery, John Radcliffe Hospital, Oxford, 5 Department of Surgery, University Hospital, Coventry, 6 Department of Physics, University of Toronto, Canada, 7 Department of Surgery, University of Toronto, 8 University of Colorado Denver Health Sciences Center, Aurora, Colorado, USA, 9 Ann Arbor, Michigan, USA

Correspondence to: P Firth pfirth{at}partners.org

Objective To examine patterns of mortality among climbers on Mount Everest over an 86 year period.

Design Descriptive study.

Setting Climbing expeditions to Mount Everest, 1921-2006.

Participants 14 138 mountaineers; 8030 climbers and 6108 sherpas.

Main outcome measure Circumstances of deaths.

Results The mortality rate among mountaineers above base camp was 1.3%. Deaths could be classified as involving trauma (objective hazards or falls, n=113), as non-traumatic (high altitude illness, hypothermia, or sudden death, n=52), or as a disappearance (body never found, n=27). During the spring climbing seasons from 1982 to 2006, 82.3% of deaths of climbers occurred during an attempt at reaching the summit. The death rate during all descents via standard routes was higher for climbers than for sherpas (2.7% (43/1585) v 0.4% (5/1231), P<0.001; all mountaineers 1.9%). Of 94 mountaineers who died after climbing above 8000 m, 53 (56%) died during descent from the summit, 16 (17%) after turning back, 9 (10%) during the ascent, 4 (5%) before leaving the final camp, and for 12 (13%) the stage of the summit bid was unknown. The median time to reach the summit via standard routes was earlier for survivors than for non-survivors (0900-0959 v 1300-1359, P<0.001). Profound fatigue (n=34), cognitive changes (n=21), and ataxia (n=12) were the commonest symptoms reported in non-survivors, whereas respiratory distress (n=5), headache (n=0), and nausea or vomiting (n=3) were rarely described.

Conclusions Debilitating symptoms consistent with high altitude cerebral oedema commonly present during descent from the summit of Mount Everest. Profound fatigue and late times in reaching the summit are early features associated with subsequent death.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Important points in analysing deaths on Mount Everest
Matiram Pun
BMJ 2009 338: b41. [Extract] [Full Text]

Everything you know is wrong
Tony Delamothe
BMJ 2008 337: a3027. [Extract] [Full Text]

Related external webpages:

Listen to Christmas 2008 BMJ podcast

This article has been cited by other articles:

  • Windsor, J S, Firth, P G, Grocott, M P, Rodway, G W, Montgomery, H E (2009). Mountain mortality: a review of deaths that occur during recreational activities in the mountains. Postgrad. Med. J. 85: 316-321 [Abstract] [Full text]  
  • Pun, M. (2009). Important points in analysing deaths on Mount Everest. BMJ 338: b41-b41 [Full text]  

Rapid Responses:

Read all Rapid Responses

Mt Everest, hypoxia and red cell deformability.
Les O. Simpson
bmj.com, 25 Dec 2008 [Full text]
Important points to cosider while analyzing the deaths of climbers on Mt Everes !
Matiram Pun
bmj.com, 27 Dec 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ